Download PDFPDF

Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008–2012: a prospective cohort study
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Response to Kan et al.
    • Yijia Li, Internal Medicine University of Pittsburgh School of Medicine

    Kan et al. nicely showed that in HIV-infected treatment-naïve first-line regimen initiators, four-year risk of virological failure (VF) and HIV drug resistance (HIVDR) were 11.8% and 5.0%, and they demonstrated that male and female participants had different risk factors for VF and HIVDR[1]. However, there are some limitations in this study that might be worth mentioning. First, in the inclusion phase, as the authors acknowledged, over half of the participants included in 2008 were lost to follow-up or excluded in 2012, which may generate selection bias. Hence, it would be important to compare the baseline characteristics in participants lost to follow-up/excluded and those who were included, in order to see whether there were any significant differences that may bias this study. Second, the authors did not account for baseline transmitted drug resistance mutation (DRM). Albeit rare, the prevalence of DRM was still 3% in treatment-naive participants in the year 2008, based on a meta-analysis[2]. As shown in a previous study in China with participants starting antiretroviral therapy (ART) between 2008-2010, baseline DRM is significantly associated with virological failure[3]. Coincidentally, this study found that HIVDR rate was 5.0%, comparable to the baseline DRM rate in the aforementioned meta-analysis. Thus, baseline DRM may actually affect HIVDR rate in this group of participants. Third, this study did not include men who have sex with men (MSM), which have become one o...

    Show More
    Conflict of Interest:
    None declared.